SCHEMBL23309715

SCHEMBL23309715

Cc1ccc(NC(=O)c2cc(F)nc(F)c2F)cc1C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SORT1 Q99523 2/20 0.46
▸ HTT P42858 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ TAS2R14 Q9NYV8 1/20 0.44
▸ KIT P10721 2/20 0.44
▸ FLT1 P17948 3/20 0.43
▸ KDR P35968 3/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ THRB P10828 1/20 0.42
▸ TMPRSS4 Q9NRS4 3/20 0.42
▸ GRM4 Q14833 1/20 0.42
▸ BRAF P15056 1/20 0.41
▸ CDK8 P49336 1/20 0.41
▸ DDT P30046 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309483 0.86 CYP1A2 (0.52) HTTSMN1; SMN2MEN1NPC1MAPT
SCHEMBL23309702 0.85 ALDH1A1 (0.55) LMNASMN1; SMN2NPC1MAPTRAB9A
SCHEMBL23309557 0.83 TMPRSS4 (0.47) FLT1KDRKMT2ATMPRSS4GRM4
SCHEMBL23309566 0.82 ALDH1A1 (0.41) SMN1; SMN2KITNPC1RAB9ABRAF
SCHEMBL23309492 0.82 RAB9A (0.45) LMNASMN1; SMN2MEN1NPC1MAPT
SCHEMBL23309539 0.82 NPC1 (0.52) HTTLMNASMN1; SMN2MEN1NPC1
SCHEMBL23309533 0.82 ALDH1A1 (0.43) LMNASMN1; SMN2KDRNPC1MAPT
SCHEMBL23309730 0.81 KMT2A (0.47) HTTLMNASMN1; SMN2MEN1NPC1
SCHEMBL23309711 0.81 GRM4 (0.53) SMN1; SMN2MEN1NPC1MAPTRAB9A
SCHEMBL23309621 0.80 RAB9A (0.50) HTTLMNASMN1; SMN2MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL SORT1 4054/4885HTT 2558/4885LMNA 3312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback